Therefore, the combined results from previous studies and our present evidence suggested that ERK1/2 represents a positive regulator in the progression of cardiac hypertrophy and is correlated with running intensity, which is, however, alleviated by increased running duration. This evidence concerns the gene MAPK3 and cardiac hypertrophy.